Dongwha Pharm.Co.Ltd (000020.KS) stock: key figures, P/E, revenue and dividend

Health Care · Pharmaceuticals · South Korea · ISIN KR7000020008

Price
5,160.00 KRW
Market cap
143.02 bn KRW
P/E (2025)
16.47
P/S (2025)
0.29
Dividend yield
1.26 %
Net margin
1.75 %
Return on equity (ROE)
2.16 %
Return on assets (ROA)
1.35 %

Dongwha Pharm.Co.Ltd financials

Fiscal year20242025
Revenue464.87 bn KRW496.39 bn KRW
Gross profit214.26 bn KRW218.55 bn KRW
Operating income13.41 bn KRW256.75 m KRW
EBIT9.05 bn KRW10.52 bn KRW
Net income5.56 bn KRW8.69 bn KRW
Diluted EPS – continuing operations200.71 KRW313.37 KRW

Full history since 2003, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About Dongwha Pharm.Co.Ltd

Dongwha Pharm.Co.,Ltd manufactures and sells pharmaceutical products in South Korea. It offers ethical products in the areas of alimentary system, antibiotic, cardiovascular/metabolic disease, NSAID/respiratory system, muscle relaxants/musculoskeletal system, nervous system, and dermatological/urinary system; OTC products in the areas of alimentary system, cold remedy, NSAID/respiratory system, dermatological, mouth and tooth, hepatic protectors, nutrients, tonics, topic analgesic, antihistamines, sore throat, and others; quasi drugs; health subsidiary foods; foods and drinks; and cosmetics. The company also exports its products. Dongwha Pharm.Co.,Ltd was founded in 1897 and is headquartered in Seoul, South Korea.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 06.11.2026. Details in the risk notice.